Globe Life (NYSE:GL) Issues Earnings Results, Misses Expectations By $0.06 EPS

Globe Life (NYSE:GL) announced its quarterly earnings data on Wednesday. The company reported $3.61 EPS for the quarter, missing the consensus estimate of $3.67 by ($0.06), Zacks reports. The company had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.59 billion. Globe Life had a return on equity of 20.94% and a net margin of 19.38%. Globe Life updated its FY 2026 guidance to 15.550-15.950 EPS.

Globe Life Stock Performance

Globe Life stock traded down $0.63 during mid-day trading on Wednesday, reaching $183.71. The company’s stock had a trading volume of 899,282 shares, compared to its average volume of 550,475. The firm’s fifty day moving average price is $167.76 and its two-hundred day moving average price is $152.23. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.07 and a current ratio of 0.07. Globe Life has a 12-month low of $122.48 and a 12-month high of $191.55. The company has a market capitalization of $14.26 billion, a P/E ratio of 12.70 and a beta of 0.47.

Globe Life Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Monday, July 6th will be issued a $0.33 dividend. The ex-dividend date of this dividend is Monday, July 6th. This represents a $1.32 annualized dividend and a yield of 0.7%. Globe Life’s dividend payout ratio (DPR) is 9.13%.

Insider Activity

In related news, Director Cheryl Alston sold 8,258 shares of the business’s stock in a transaction on Thursday, June 25th. The stock was sold at an average price of $179.24, for a total transaction of $1,480,163.92. Following the sale, the director directly owned 16,621 shares in the company, valued at approximately $2,979,148.04. The trade was a 33.19% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Thomas Peter Kalmbach sold 7,936 shares of the stock in a transaction dated Friday, May 22nd. The stock was sold at an average price of $156.59, for a total value of $1,242,698.24. Following the sale, the chief financial officer directly owned 50,496 shares in the company, valued at $7,907,168.64. This trade represents a 13.58% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 124,187 shares of company stock valued at $19,529,414. 2.11% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Globe Life

Hedge funds and other institutional investors have recently modified their holdings of the stock. NewEdge Advisors LLC increased its holdings in Globe Life by 368.1% during the 1st quarter. NewEdge Advisors LLC now owns 6,806 shares of the company’s stock worth $897,000 after acquiring an additional 5,352 shares during the period. Federation des caisses Desjardins du Quebec boosted its holdings in Globe Life by 13.1% in the 4th quarter. Federation des caisses Desjardins du Quebec now owns 6,326 shares of the company’s stock valued at $885,000 after purchasing an additional 732 shares during the period. Tower Research Capital LLC TRC grew its position in shares of Globe Life by 159.8% during the 3rd quarter. Tower Research Capital LLC TRC now owns 4,582 shares of the company’s stock valued at $655,000 after purchasing an additional 2,818 shares in the last quarter. EP Wealth Advisors LLC purchased a new position in shares of Globe Life during the 4th quarter valued at $470,000. Finally, Empowered Funds LLC bought a new position in shares of Globe Life in the first quarter worth $428,000. 81.61% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on GL. Morgan Stanley raised their price target on shares of Globe Life from $181.00 to $208.00 and gave the stock an “overweight” rating in a research note on Monday, July 6th. Jefferies Financial Group upped their price objective on Globe Life from $147.00 to $166.00 and gave the company a “hold” rating in a research note on Friday, July 10th. JPMorgan Chase & Co. increased their price objective on Globe Life from $181.00 to $201.00 and gave the company an “overweight” rating in a report on Tuesday. Truist Financial boosted their target price on Globe Life from $180.00 to $185.00 and gave the company a “buy” rating in a research note on Friday, April 24th. Finally, Weiss Ratings cut Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a research report on Monday. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $187.60.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.